by Mike ‘Mish’ Shedlock
The Street
Johnson & Johnson starts a 60,000 person phase-3 trial test. Stage-3 is the final phase.
The Wall Street Journal reports Johnson & Johnson Begins Final-Stage Testing of Covid-19 Vaccine.
Key Details
– J&J aims to enroll adult volunteers in the U.S. and several other countries, including Brazil and South Africa.
– A vaccine that Moderna Inc. codesigned with the National Institute of Allergy and Infectious Diseases started Phase 3 testing in July and has enrolled nearly 26,000 people toward a goal of 30,000.